Preservation of mitochondrial mass in a translational model of prolonged fasting and atrophy resistance

Active Grant Awarded

Award ID
R16GM165739
Recipient
Awarding agency
Obligated
$193,750

Award facts

Assistance listing
93.859 Biomedical Research and Research Training
Completion date 5% complete
Place of performance
Fairbanks, AK 99775, USA

Award details come from USAspending.gov.

About this award

The U.S. Department of Health and Human Services, National Institutes of Health, National Institute of General Medical Sciences awarded Grant R16GM165739 to University of Alaska Fairbanks on September 9, 2026, with $193,750 obligated. The award falls under Biomedical Research and Research Training (CFDA 93.859), and NIGMS supports basic research on biological processes that underpin advances in disease diagnosis, treatment, and prevention.

The funded work examines whether cold exposure and hibernation, individually or jointly, preserve skeletal muscle mitochondrial homeostasis during extreme inactivity, using black bears as a translational model for muscle atrophy in older, bedbound, and critically ill patients. The project hypothesizes that cold exposure and hibernation cooperatively maintain mitochondrial muscle mass by balancing mitochondrial biogenesis and mitophagy through novel regulatory pathways. The first aim is to determine the relative contributions of cold exposure and seasonal hibernation to preserving skeletal muscle mitochondrial abundance and homeostasis.

Performance runs from the September 2026 award date through an ultimate completion date of May 31, 2030, with work based at Fairbanks, Alaska 99775.

Description

Abstract
Muscle atrophy directly contributes to a lower quality of life and is associated with enhanced comorbidities and mortality in older and bedbound populations, and those recovering from critical illness. Decreased mitochondrial biogenesis, dysregulated mitochondrial function, and loss of mitochondrial abundance are associated with muscle atrophy. Both mitochondrial biogenesis and mitophagy can enhance muscle function and mitochondrial mass, but these mechanisms are poorly understood. Despite this association being well established, there are few treatments, besides exercise pre-habilitation, that improve mitochondrial abundance and muscle recovery. Thus, there is a critical need for novel therapeutics that directly assist with retention of mitochondrial abundance in mobility challenged older populations and bedbound patients facing muscle atrophy. Black bears are a highly translational model due to their comparative size to humans and anatomy, and are the only human-sized model known to resist muscle atrophy under extreme fasting. Both intrinsic hibernation molecular mechanisms and cold exposure stress potentially contribute to mitochondrial homeostasis. The long-term goal of this work is to translate adaptive mechanisms of mitochondrial resilience to clinical muscle atrophy populations. The overall objective of this proposal is to determine how cold exposure and hibernation individually, or jointly, contribute to skeletal muscle mitochondrial homeostasis during extreme inactivity. Our overarching hypothesis is that cold exposure and hibernation cooperatively maintain mitochondrial muscle mass by maintaining balanced mitochondrial biogenesis and mitophagy through novel regulatory pathways. Our first aim is to determine relative contributions of cold exposure and seasonal hibernation in preserving skeletal muscle mitochondrial abundance and homeostasis during atrophy resistance. Our second aim is to identify key mitochondrial proteins and mitochondrial-derived genes driving mitochondrial maintenance during cold exposure and hibernation. The expected outcomes for this R16 sure first proposal are to identify novel regulators of mitochondrial biogenesis and mitophagy in skeletal muscle during atrophy resistance, and identify proteins and genes involved in maintaining mitochondrial density during hibernation and cold exposure. Results from this proposed research will enable US to identify the molecular underpinnings of mitochondrial homeostasis during atrophy resistance. This work will also establish the role of cold temperature in maintaining skeletal muscle mitochondrial mass and health, and will guide development of an independent R01 proposal by DR. Rice to directly test novel mechanisms for enhancing mitochondrial health and retention. Lastly, this work will assist in developing of new biomedical techniques at the university of alaska fairbanks (UAF) and directly support undergraduate biomedical training opportunities.

Quick answers

Who received award R16GM165739?

R16GM165739 was awarded to University Of Alaska Fairbanks by National Institute of General Medical Sciences (National Institutes of Health) on September 9, 2026.

How much is award R16GM165739 worth?

$193,750 has been obligated on R16GM165739.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award